REFERENCES
Supplement: Abstracts, 4th International Conference on Drug Absorption, Edinburgh. Eur. J. Pharm. Sci., 5/Suppl. 2:(1997).
A. J. Shaw. Epithelial cell culture—a practical approach, Oxford University Press, Oxford, 1996.
R. Borchardt, P. Smith, and G. Wilson. Models for assessing drug absorption and metabolism, Plenum Press, New York, 1996.
J. Hochman and P. Artursson. Cell cultures to assess drug transport and metabolism. Adv. Drug. Deliv. Rev., 22:1–265 (1996).
P. Smith. In vitro models for selection of development candidates. Adv. Drug. Deliv. Rev., 23:1–235 (1997).
R. Borchardt. The application of cell culture systems in drug discovery and development. J. Drug Targeting, 3:179–182 (1995).
D. Brayden. Human intestinal epithelial cell monolayers as prescreens for oral drug delivery. Pharm. News, 4:11–15 (1997).
S. Yee. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man-fact or myth. Pharm. Res., 14:763–766 (1997).
K. Covitz, G. Amidon, and W. Sadee. Human dipeptide transporter, hPEPT1, stably transfected into Chinese hamster ovary cells. Pharm. Res., 13:1631–1634 (1996).
C. Crespi, B. Penman, and M. Hu. Development of Caco-2 cells expressing high levels of cDNA-derived cytochrome P450 3A4. Pharm. Res., 13:1635–1641 (1996).
P. Schmiedlin-Ren, K. Thummel, J. Fischer, M. Paine, K. Lown, and P. Watkins. Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1-alpha, 25-dihydroxyvitamin D3. Mol. Pharmacol., 51:741–754 (1997).
S. Kerneis, A. Bogdanova, J. Kraehenbuhl, and E. Pringault. Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. Science, 277:949–952 (1997).
D. Asa and P. LaRocca. Comparison of the Biocoat® intestinal epithelial environment with the conventional 21-day Caco-2 system. Poster presentation at the 4th International Conference on Drug Absorption, Edinburgh, 1997.
E. Walter and T. Kissel. Heterogeneity in the human intestinal cell line Caco-2 leads to differences in transepithelial transport. Eur. J. Pharm. Sci., 3:215–230 (1995).
V. Milovic, S. Olsson, J. Hochman, E. Paul, and P. Artursson. Conditionally immortalised rat fetal intestinal epithelial cell line (2/4/A1) for studying epithelial differentiation, apoptosis and permeability. Gastroenterology, 110:A822 (1996).
A. Wikman, J. Karlsson, I. Carlstedt, and P. Artursson. A drug absorption model based on the mucus layer producing human intestinal epithelial goblet cell line HT29-H. Pharm. Res., 10:843–852 (1993).
G. Pang, A. Buret, E. O'Loughlin, A. Smith, R. Batey, and R. Clancy. Immunologic, functional and morphological characterization of three new human small intestinal epithelial cell lines. Gastroenterology, 111:8–18 (1996).
A. Wikman and P. Artursson. Co-cultures of human intestinal goblet (HT29-H) and absorptive (Caco-2) cell for studies of epithelial transport and integrity. Eur. J. Pharm. Sci., 3:171–183 (1995).
A. Quaroni and J. Hochman. Development of intestinal cell culture models for drug transport and metabolism studies. Adv. Drug. Deliv. Rev., 22:3–52 (1996).
W. H. Moos, G. D. Green, and M. R. Pavia. Recent advances in the generation of molecular diversity. Annu. Rep. Med. Chem., 28:315–324 (1993).
E. W. Taylor, J. A. Gibbons, and R. A. Braeckman. Intestinal absorption screening of mixtures from combinatorial libraries in the Caco-2 model. Pharm. Res., 14:572–577 (1997).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Artursson, P., Borchardt, R.T. Intestinal Drug Absorption and Metabolism in Cell Cultures: Caco-2 and Beyond. Pharm Res 14, 1655–1658 (1997). https://doi.org/10.1023/A:1012155124489
Issue Date:
DOI: https://doi.org/10.1023/A:1012155124489